JAGX Stock Analysis: Buy, Sell, or Hold?
JAGX - Jaguar Health, Inc.
$0.23
-0.02 (-6.39%)
▼
5d:
-44.95%
30d:
-32.25%
90d:
-66.6%
WAIT
LOW Confidence
Analysis Updated: Apr 29, 2026 12:00 AM ET
Earnings: May 21, 2026
21d
Get Alerted When JAGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: JAGX is down 44.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: JAGX is down 44.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: JAGX is currently trading at $0.23, which is considered oversold relative to its 30-day fair value range of $0.33 to $0.43.
Technical Outlook: Technically, JAGX is in a strong downtrend. The price is currently testing key support at $0.23. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+3012.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JAGX is in a strong downtrend. The price is currently testing key support at $0.23. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+3012.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.33 -
$0.43
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.4%)
- BULLISH: Trading 3012.0% below Wall St target ($7.50)
- WARNING: Recommendation downgraded due to -44.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.33 -
$0.43
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.23
Resistance Level
$0.44
Current Trend
Strong Downtrend
Technical data as of
Apr 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.89
Wall Street Target
$7.50
(+3012.0%)
Revenue Growth (YoY)
-7.8%
Share & Embed Analysis
Last updated: April 29, 2026 2:41 PM ET
Data refreshes hourly during market hours. Next update: 3:41 PM
Data refreshes hourly during market hours. Next update: 3:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JAGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 60 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$878 | 49 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 54 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 51 HOLD |
